A role for IL-27p28 as an antagonist of gp130-mediated signaling.
about
Interleukin-27: balancing protective and pathological immunityThe Regulation of CD4(+) T Cell Responses during Protozoan InfectionsThe emerging role of Interleukin 27 in inflammatory arthritis and bone destructionTherapeutic strategies for the clinical blockade of IL-6/gp130 signalingFrom IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokinesBiology of IL-27 and its role in the host immunity against Mycobacterium tuberculosisInterleukin-27 in T cell immunityExpanding Diversity in Molecular Structures and Functions of the IL-6/IL-12 Heterodimeric Cytokine FamilyIL-27R signaling controls myeloid cells accumulation and antigen-presentation in atherosclerosis.Interleukin-35 induces regulatory B cells that suppress autoimmune disease.Tyrosine kinase 2 promotes sepsis-associated lethality by facilitating production of interleukin-27Decreased interleukin 27 expression is associated with active uveitis in Behçet's diseaseIL-12 family cytokines: immunological playmakersAAV2-mediated subretinal gene transfer of mIL-27p28 attenuates experimental autoimmune uveoretinitis in miceInterruption of macrophage-derived IL-27(p28) production by IL-10 during sepsis requires STAT3 but not SOCS3.IL-30 (IL27p28) attenuates liver fibrosis through inducing NKG2D-rae1 interaction between NKT and activated hepatic stellate cells in miceEpstein Barr virus-induced 3 (EBI3) together with IL-12 negatively regulates T helper 17-mediated immunity to Listeria monocytogenes infection.Gastric epithelial expression of IL-12 cytokine family in Helicobacter pylori infection in human: is it head or tail of the coin?Skin-resident murine dendritic cell subsets promote distinct and opposing antigen-specific T helper cell responses.Cytokines in autoimmune uveitis.Induction of regulatory Tr1 cells and inhibition of T(H)17 cells by IL-27.Distinct subunit pairing criteria within the heterodimeric IL-12 cytokine family.Interleukin 27R regulates CD4+ T cell phenotype and impacts protective immunity during Mycobacterium tuberculosis infection.Interleukin 12 (IL-12) family cytokines: Role in immune pathogenesis and treatment of CNS autoimmune disease.IL-27 Limits Type 2 Immunopathology Following Parainfluenza Virus Infection.Novel IL27p28/IL12p40 cytokine suppressed experimental autoimmune uveitis by inhibiting autoreactive Th1/Th17 cells and promoting expansion of regulatory T cellsIL-27 production and STAT3-dependent upregulation of B7-H1 mediate immune regulatory functions of liver plasmacytoid dendritic cells.Gene therapy using IL-27 ameliorates Sjögren's syndrome-like autoimmune exocrinopathy.Interleukin-27 as a Novel Biomarker for Early Cardiopulmonary Failure in Enterovirus 71-Infected Children with Central Nervous System InvolvementModulation of inflammation by interleukin-27.Dual Roles of IFN-γ and IL-4 in the Natural History of Murine Autoimmune Cholangitis: IL-30 and Implications for Precision Medicine.Evaluating the potential of IL-27 as a novel therapeutic agent in HIV-1 infection.IL-27p28 inhibits central nervous system autoimmunity by concurrently antagonizing Th1 and Th17 responses.Anti-interleukin-6 receptor antibody, tocilizumab, for the treatment of autoimmune diseases.Role of innate cytokines in mycobacterial infection.Molecular interactions within the IL-6/IL-12 cytokine/receptor superfamily.Interpreting mixed signals: the cell's cytokine conundrum.New directions in the basic and translational biology of interleukin-27.Cytokines in the balance of protection and pathology during mycobacterial infections.gp130: a promising drug target for cancer therapy.
P2860
Q26830400-644C69FC-EB4C-4252-BB14-4068C3A305A7Q26865518-C5C9AEF3-D1D6-4FBD-B499-5B843750628EQ26995207-2D320677-373E-4FB5-9F0A-E5A2D005B6FBQ27002391-24F20932-F55B-4C19-8193-AFBBBEF6332DQ27008912-1395539D-2B8C-4FA7-A009-A992944F3E86Q27014743-7DCF18C1-6995-4435-8EA2-1C3712161BCBQ27022577-CADD6911-A1AE-4BD3-910E-C0CAEC6541EFQ28075849-3290257C-3A8E-475C-8784-5FF886CECE67Q30852948-21FDE687-4E5B-4004-85DA-4EB117964B0CQ33721777-27A1FF6E-87CC-4B64-82CA-A2F0988BD230Q33750852-E76B937C-6997-409F-B924-58B3B46F5D5CQ33892832-21A88CAD-4CBD-486D-83BC-91F51C9306D4Q34153998-2BE52969-E756-415F-9D11-AC3E289974FDQ34282130-EF2C8D88-97FC-41E9-86D1-A42F0D79A9ACQ34550651-48D8D9CE-8D97-4E33-A3E5-227AF5EDE1A1Q34577122-F18A95A2-9BF4-450B-AE9E-67F4B5030489Q34998232-6FFA521B-56B9-4CBF-97A0-F3EF21225C5EQ34999507-9717DC5A-2E23-4CB8-A6D6-7847EC03CCA4Q35184456-23A773CE-1115-4C5D-A97C-8CAE06D56CAAQ35294461-10F3E2D6-B7D1-4E26-BED3-7DB4145035AAQ35592657-EE3A8C3F-1EBA-41FD-A382-2C32E936DFBAQ35926091-A38E2A67-BC69-4385-870B-49B3DB29D59FQ35992186-5D4E0523-23C2-4200-B746-7478C486D87BQ36005974-76C9A9E6-3D07-4DC2-A497-A761EC4EB1BDQ36262581-37721F83-D50A-4546-84EC-9C770A4A6A74Q36332796-624FB006-CE7F-4B95-9B34-AA699C749C0BQ36587981-FEDCBCA1-925B-4FF6-A240-4B60449EE286Q36633351-09585D5F-531C-419E-ABB3-9D40E448ECBFQ37049338-36150A96-26DA-41C7-8777-9DB7926F76A9Q37309924-31B93B44-95D2-4E1F-BA98-AEA5480CD016Q37324268-7EA6A4DF-8B18-4BCC-BB3D-0857B4BCD93BQ37365279-C1F4BE80-8DEA-4B14-BD12-0574C693ADB4Q37684639-37ED6EDC-0235-4E19-B4BA-645F4580D7ADQ37854935-5EB7338A-E159-4522-A97C-E4746BCC4E95Q37856711-B20346B5-B279-49A0-BDE1-3F19907EC0FEQ37873404-F14F3870-BEA2-4A58-8F48-FB6D3B55CEF5Q37919660-0100D116-A44F-45D6-8C57-B6FDA8AE3507Q37969347-E65B3B93-5DA3-460C-894C-37FD09B70837Q38087271-B3EF3711-678F-4FA5-AD31-16A366DABD6AQ38149939-564F7E45-EEDD-4A65-89FD-081B90839997
P2860
A role for IL-27p28 as an antagonist of gp130-mediated signaling.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A role for IL-27p28 as an antagonist of gp130-mediated signaling.
@ast
A role for IL-27p28 as an antagonist of gp130-mediated signaling.
@en
A role for IL-27p28 as an antagonist of gp130-mediated signaling.
@nl
type
label
A role for IL-27p28 as an antagonist of gp130-mediated signaling.
@ast
A role for IL-27p28 as an antagonist of gp130-mediated signaling.
@en
A role for IL-27p28 as an antagonist of gp130-mediated signaling.
@nl
prefLabel
A role for IL-27p28 as an antagonist of gp130-mediated signaling.
@ast
A role for IL-27p28 as an antagonist of gp130-mediated signaling.
@en
A role for IL-27p28 as an antagonist of gp130-mediated signaling.
@nl
P2093
P2860
P50
P356
P1433
P1476
A role for IL-27p28 as an antagonist of gp130-mediated signaling.
@en
P2093
Aisling C O'Hara
Björn Spudy
Christiaan J M Saris
Christopher A Hunter
Daniel J Cua
Jason S Stumhofer
Joachim Grötzinger
Merle M Elloso
Michael L Jones
Michael P Cancro
P2860
P2888
P304
P356
10.1038/NI.1957
P407
P577
2010-11-07T00:00:00Z
P5875
P6179
1018476761